Natural Cyclic Peptides as Clinical and Future Therapeutics

被引:7
作者
Bera, Smritilekha [1 ]
Mondal, Dhananjoy [1 ]
机构
[1] Cent Univ Gujarat, Sch Chem Sci, Gandhinagar 382030, India
关键词
Natural products; cyclic peptides; clinical drugs; antifungal; antibacterial; anticancer; anti-HIV; HISTONE DEACETYLASE INHIBITORS; ANTIMITOTIC BICYCLIC PEPTIDES; RESPIRATORY-TRACT INFECTIONS; BIOACTIVE MARINE METABOLITES; STREPTOMYCES-ALBOFLAVUS; 313; NEW-GUINEA COLLECTION; CANCER CELL-GROWTH; AZUMAMIDES-A-E; ANTINEOPLASTIC AGENTS; RGD PEPTIDE;
D O I
10.2174/1385272823666190110103558
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Natural cyclic peptides are conformationally constrained notable biomolecules and reveal several drug-like properties such as high binding affinity, metabolic stability, target selectivity, bioavailability, low toxicity and flexibility. They have attracted a lot of attention as alternative sources of new drugs to traditional small molecules in drug discovery. Compared to classical medicines, cyclic peptides with a novel mechanism of action are attractive for their potential therapeutic applications particularly for cancer therapy and several diseases caused by resistant and non-resistant bacteria, virus, and fungi. Herein, we provide an overview of the naturally occurring biologically active cyclic peptide therapeutic landscape, including promising candidates, which are under trial in different stages for future and/or clinically used drugs against different diseases. This will certainly be an essential resource for upcoming and existing researchers and scientists within industry and academia in medicinal, bioorganic, and natural product chemistry.
引用
收藏
页码:38 / 75
页数:38
相关论文
共 398 条
[1]   THE STRUCTURES OF SULFOMYCIN-I AND BERNINAMYCIN-A [J].
ABE, H ;
KUSHIDA, K ;
SHIOBARA, Y ;
KODAMA, M .
TETRAHEDRON LETTERS, 1988, 29 (12) :1401-1404
[2]   Converting a peptide into a drug: Strategies to improve stability and bioavailability [J].
Adessi, C ;
Soto, C .
CURRENT MEDICINAL CHEMISTRY, 2002, 9 (09) :963-978
[3]   Carteritins A and B, cyclic heptapeptides from the marine sponge Stylissa carteri [J].
Afifi, Ahmed H. ;
El-Desoky, Ahmed H. ;
Kato, Hikaru ;
Mangindaan, Remy E. P. ;
de Voogd, Nicole J. ;
Ammar, Nagwa M. ;
Hifnawy, Mohammed S. ;
Tsukamoto, Sachiko .
TETRAHEDRON LETTERS, 2016, 57 (11) :1285-1288
[4]   Therapeutic cancer targeting peptides [J].
Aina, OH ;
Sroka, TC ;
Chen, ML ;
Lam, KS .
BIOPOLYMERS, 2002, 66 (03) :184-199
[5]   Structures of pahayokolides A and B, cyclic peptides from a Lyngbya sp. [J].
An, Tianying ;
Kumar, Thallapuranam Krishnaswamy Suresh ;
Wang, Minglei ;
Liu, Li ;
Lay, Jackson O., Jr. ;
Liyanage, Rohana ;
Berry, John ;
Gantar, Miroslav ;
Marks, Vered ;
Gawley, Robert E. ;
Rein, Kathleen S. .
JOURNAL OF NATURAL PRODUCTS, 2007, 70 (05) :730-735
[6]   Cyclodepsipeptides from Marine Sponges: Natural Agents for Drug Research [J].
Andavan, Gowri Shankar Bagavananthem ;
Lemmens-Gruber, Rosa .
MARINE DRUGS, 2010, 8 (03) :810-834
[7]  
Andreu D, 1998, BIOPOLYMERS, V47, P415, DOI 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO
[8]  
2-D
[9]  
[Anonymous], PEPTIDES ANAL SYNTHE
[10]  
[Anonymous], 2018, ANTI-CANCER DRUG, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]